Your boss wants you to take a Covid-19 test. There’s software for that
As more employers reopen their doors, health tech companies are pitching digital tools to help them bring employees back to work safely in the Covid-19 era.
As more employers reopen their doors, health tech companies are pitching digital tools to help them bring employees back to work safely in the Covid-19 era.
The new funding led by General Catalyst and 7wireVentures values Transcarent at $2.2 billion, will be used for AI projects, acquisitions.
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
Scientists are frustrated that the USDA again failed to include basic information about H5N1 genetic sequences from cows when the data were released this week.
The special sauce of primary care will not be saved until the overwhelming number of quality metrics that primary care providers must complete is winnowed…
After years on the rise, the U.S. maternal mortality rate decreased in 2022, new government data show. But maternal health experts warn there’s no reason…
On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack kicked off a cascading series of
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
The FTC is broadening its campaign to curb alleged patent abuses by the pharma industry, disputing over 300 patent listings across 20 drugs including Ozempic.
Despite its devastating impact, colorectal cancer is the only top-five cancer killer without its own research program within the Department of Defense’s Congressionally Directed Medical…
Wastewater surveillance, which demonstrated great potential during the Covid-19 pandemic, remains vastly under-leveraged for H5N1 bird flu at this precarious moment.